About Contact Us Careers

Psilocybin Assisted Therapy Market Share

Request Free Sample Copy

Report ID: 4330
Published Date: Nov 19, 2024
Report Format: PDF, PPT

Buy Now

Psilocybin Assisted Therapy Market Share

Regionally, the global psilocybin assisted therapy market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to dominate majority revenue share by 2036, led by higher growth rate in the intranasal segment as companies launch novel psychedelic sprays and proven efficacy increases its popularity.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Psilocybin Assisted Therapy Market Size & Share | Growth Analysis 2036

Author Credits: Radhika Pawar

Report ID: 4330
Published Date: Nov 19, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The psilocybin assisted therapy industry size is anticipated to witness more than 4.3% CAGR during the forecast period i.e., between 2024-2036.

Rising prevalence of depression and mental disorders and high use in the treatment of anxiety will impel the market growth.

North America industry is predicted to dominate majority revenue share by 2036, led by higher growth rate in the intranasal segment as companies launch novel psychedelic sprays and proven efficacy increases its popularity.

The major players in the market are Cybin Irl Limited, Mind Medicine Inc., COMPASS Pathways plc, Atai Life Sciences N.V., Fieldtrip, LLC., DemeRx, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals Inc, Pfizer Inc., Others.

Inquiry Before Buying Request Free Sample